In The News
Armour takeover case against Baker McKenzie can’t boost damages to $135M
Banksia silk wants to cross-examine prosecutor’s witnesses in criminal case
India wins foreign state immunity appeal in fight over $111.3M arbitral award
$3M class action settlement over Nine’s Palm Island coverage wins approval
EDO rejects financial concerns after paying Santos legal costs
Contest between rival Google ad tech class actions on the cards
Large swath of Australia’s chief legal officers don’t report to the big boss
Pawn shop class action lead applicant MIA, court hears
HWL Ebsworth had legitimate interest in expelling older partner: appeals court
Law firms team up to file competing Google ad tech class action
Please login to bookmark Close

US biotech giant Gilead has struck back at a patent infringement lawsuit brought by a specialist HIV pharmaceutical company majority owned by GlaxoSmithKline, saying the patent at the centre of the lawsuit is invalid.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au